Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

This study was intended to determine the efficacy of nivolumab, we evaluated treatment response with respect to PD-1/PD-L1 SNPs among patients with NSCLC. A total of 50 patients with NSCLC were treated with nivolumab and were also evaluated for PD-1/PD-L1 single nucleotide polymorphisms (SNPs) from...

Descripción completa

Detalles Bibliográficos
Autores principales: Nomizo, Takashi, Ozasa, Hiroaki, Tsuji, Takahiro, Funazo, Tomoko, Yasuda, Yuto, Yoshida, Hironori, Yagi, Yoshitaka, Sakamori, Yuichi, Nagai, Hiroki, Hirai, Toyohiro, Kim, Young Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362817/
https://www.ncbi.nlm.nih.gov/pubmed/28332580
http://dx.doi.org/10.1038/srep45124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362817/
https://www.ncbi.nlm.nih.gov/pubmed/28332580
http://dx.doi.org/10.1038/srep45124

Ejemplares similares